These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2755529)

  • 21. Development of modern anti-ulcer drugs.
    Garner A
    Br J Clin Pract Suppl; 1994; 75():1-5; discussion 6-8. PubMed ID: 7914740
    [No Abstract]   [Full Text] [Related]  

  • 22. [Selective muscarinic receptor antagonists].
    Kishimoto S; Kajiyama G; Miyoshi A
    Nihon Rinsho; 1984 Jan; 42(1):114-9. PubMed ID: 6371305
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antagonists of the histamine H2 receptors in the stomach].
    Landa L
    Gac Med Mex; 1981 Dec; 117(12):472-4. PubMed ID: 6123460
    [No Abstract]   [Full Text] [Related]  

  • 24. Proton pump inhibitors and acid-related diseases.
    Sachs G
    Pharmacotherapy; 1997; 17(1):22-37. PubMed ID: 9017763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach].
    Sosnowski M
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1469-72. PubMed ID: 3008128
    [No Abstract]   [Full Text] [Related]  

  • 26. Helicobacter pylori and its involvement in gastritis and peptic ulcer formation.
    Konturek SJ; Konturek PC; Konturek JW; Plonka M; Czesnikiewicz-Guzik M; Brzozowski T; Bielanski W
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():29-50. PubMed ID: 17033104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of gastroduodenal ulcer with ulcosilvanil].
    Puşcaş I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(1):49-61. PubMed ID: 2884711
    [No Abstract]   [Full Text] [Related]  

  • 28. [The therapeutic arsenal in the medical treatment of gastroduodenal ulcer disease].
    Vallot T; Bonfils S
    Rev Prat; 1985 Feb; 35(9):449-57. PubMed ID: 3983550
    [No Abstract]   [Full Text] [Related]  

  • 29. [Will anti-ulcer drugs soon differ only in their side effects?].
    Miederer SE
    Fortschr Med; 1986 Dec; 104(3):918-20. PubMed ID: 2881864
    [No Abstract]   [Full Text] [Related]  

  • 30. The limitations of current therapy in peptic ulcer disease.
    Salena BJ; Hunt RH
    Clin Invest Med; 1987 May; 10(3):171-7. PubMed ID: 3304747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of peptic aggression by sucralfate. The view from the ulcer crater.
    Samloff IM
    Scand J Gastroenterol Suppl; 1983; 83():7-11. PubMed ID: 6415806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
    Gorshkov VA
    Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
    [No Abstract]   [Full Text] [Related]  

  • 33. [Appraisal of therapeutic agents for peptic ulcer by continuous intragastric pH monitoring].
    Saeki S; Tomofuji Y; Yasuda T; Mitooka H; Onoyama Y; Baba S
    Rinsho Byori; 1984 Oct; 32(10):1076-83. PubMed ID: 6549190
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of grandaxine in the treatment of patients with erosive-ulcerative stomach and gastroduodenal lesions].
    Vakhrushev IaM; Belova EV; Efremova LI
    Eksp Klin Gastroenterol; 2004; (4):21-4. PubMed ID: 15568662
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current trends in the pharmacotherapy of peptic ulcer (a review of the literature)].
    Degtiareva II
    Vrach Delo; 1985 Aug; (8):45-50. PubMed ID: 3907131
    [No Abstract]   [Full Text] [Related]  

  • 36. Gastric anti-ulcer and cytoprotective effect of l-serine in rats.
    Tariq M; Al Moutaery AR
    Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):171-84. PubMed ID: 9344230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Peptic ulcer and gastro-esophageal reflux].
    Delfosse M
    J Pharm Belg; 2000; 55(2):33-9. PubMed ID: 10842924
    [No Abstract]   [Full Text] [Related]  

  • 38. Aspects of the theoretical basis and clinical relevance of low acid states.
    Modlin IM; Goldenring JR; Lawton GP; Hunt R
    Am J Gastroenterol; 1994 Mar; 89(3):308-18. PubMed ID: 8122637
    [No Abstract]   [Full Text] [Related]  

  • 39. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA
    Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical treatment of peptic ulcer disease.
    Ohning G; Soll A
    Am Fam Physician; 1989 Apr; 39(4):257-70. PubMed ID: 2650509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.